The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer.

The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer.

Oncotarget. 2017 Mar 28;:

Authors: Zhang J, Wu N, Zhang T, Sun T, Su Y, Zhao J, Mu K, Jin Z, Gao M, Liu J, Gu L

Abstract
PURPOSE: The fragile-site associated tumor suppressor (FATS) is a newly identified tumor suppressor involved in radiation-induced tumorigenesis. The purpose of this study was to characterize FATS expression in breast cancers about radiotherapy benefit, patient characteristics, and prognosis.
RESULTS: The expression of FATS mRNA was silent or downregulated in 95.2% of breast cancer samples compared with paired normal controls (P < .0001). Negative status of FATS was correlated with higher nuclear grade (P = .01) and shorter disease-free survival (DFS) of breast cancer (P = .036). In a multivariate analysis, FATS expression showed favorable prognostic value for DFS (odds ratio, 0.532; 95% confidence interval, 0.299 to 0.947; (P = .032). Furthermore, improved survival time was seen in FATS-positive patients receiving radiotherapy (P = .006). The results of multivariate analysis revealed independent prognostic value of FATS expression in predicting longer DFS (odds ratio, 0.377; 95% confidence interval, 0.176 to 0.809; P = 0.012) for patients receiving adjuvant radiotherapy. In support of this, reduction of FATS expression in breast cancer cell lines, FATS positive group significantly sensitized than Knock-down of FATS group.
MATERIALS AND METHODS: Tissue samples from 156 breast cancer patients and 42 controls in tumor bank were studied. FATS gene expression was evaluated using quantitative reverse transcription polymerase chain reaction (qRT-PCR). FATS function was examined in breast cancer cell lines using siRNA knock-downs and colony forming assays after irradiation.
CONCLUSIONS: FATS status is a biomarker in breast cancer to identify individuals likely to benefit from radiotherapy.

PMID: 28402275 [PubMed - as supplied by publisher]

http://ift.tt/2pbQCer